First Mercantile Trust’s Haemonetics HAE Stock Holding History

First Mercantile Trust’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$86K	Sell	1,222 -19	-2%	-$1.2K	0.01%	701
2021 Q2	$83K	Buy	+1,241	New	+$87.8K	0.01%	734
2020 Q2	–	Sell	-1,253	Closed	-$125K	–	901
2020 Q1	$125K	Sell	1,253 -383	-23%	-$41.5K	0.02%	495
2019 Q4	$188K	Buy	1,636 +172	+12%	+$20.8K	0.02%	481
2019 Q3	$185K	Hold	1,464	–	–	0.02%	502
2019 Q2	$176K	Buy	+1,464	New	+$144K	0.02%	486
2019 Q1	–	Sell	-4,287	Closed	-$429K	–	884
2018 Q4	$429K	Sell	4,287 -2,364	-36%	-$248K	0.1%	226
2018 Q3	$762K	Buy	6,651 +34	+0.5%	+$3.52K	0.15%	156
2018 Q2	$593K	Buy	6,617 +1,889	+40%	+$160K	0.12%	207
2018 Q1	$346K	Buy	4,728 +430	+10%	+$29.5K	0.07%	330
2017 Q4	$250K	Sell	4,298 -4,970	-54%	-$262K	0.05%	472
2017 Q3	$416K	Sell	9,268 -156	-2%	-$6.48K	0.08%	346
2017 Q2	$372K	Sell	9,424 -7,776	-45%	-$319K	0.07%	368
2017 Q1	$698K	Sell	17,200 -260	-1%	-$10.2K	0.11%	238
2016 Q4	$702K	Buy	17,460 +9,560	+121%	+$360K	0.11%	237
2016 Q3	$286K	Sell	7,900 -5,300	-40%	-$182K	0.04%	530
2016 Q2	$383K	Buy	13,200 +4,350	+49%	+$131K	0.05%	467
2016 Q1	$310K	Sell	8,850 -7,300	-45%	-$236K	0.04%	523
2015 Q4	$521K	Sell	16,150 -11,800	-42%	-$383K	0.05%	426
2015 Q3	$903K	Sell	27,950 -957	-3%	-$36K	0.09%	294
2015 Q2	$1.2M	Buy	+28,907	New	+$1.22M	0.1%	260
2014 Q2	–	Sell	-1,680	Closed	-$55K	–	1225
2014 Q1	$55K	Sell	1,680 -16,713	-91%	-$639K	﹤0.01%	1026
2013 Q4	$775K	Sell	18,393 -226	-1%	-$9.3K	0.06%	452
2013 Q3	$743K	Buy	18,619 +2,280	+14%	+$95.7K	0.06%	464
2013 Q2	$676K	Buy	+16,339	New	+$661K	0.06%	456

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Mercantile Trust's HAE Position: Q3 2021 in Review

First Mercantile Trust reduced its Haemonetics (HAE) stake by 1.5% in Q3 2021, selling an estimated $1.2K and leaving 1,222 shares worth $86K. The position accounts for 0.01% of the portfolio, ranked #701.

First Mercantile Trust first reported a position in HAE in Q2 2013 and has held it in 25 quarters since. The position peaked at $1.2M in Q2 2015. 245 funds tracked by Wall St. Rank hold HAE as of Q3 2021.

First Mercantile Trust held 1,222 shares of Haemonetics worth $86K as of Q3 2021.
First Mercantile Trust sold 19 Haemonetics shares in Q3 2021, an estimated $1.2K.
Haemonetics made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #701 holding.
First Mercantile Trust first reported a position in Haemonetics in Q2 2013 and has held it in 25 quarters since.
First Mercantile Trust's Haemonetics position peaked at $1.2M in Q2 2015.
245 funds tracked by Wall St. Rank held Haemonetics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.